Dr. Ayesha Zia is a pediatric hematologist at the Children's Medical Center's Hemostasis Thrombosis Center, and the University of Texas Southwestern School of Medicine. Previous NHF (National Hemophilia Foundation) clinical fellowship award recipient, her clinical/translational research interests are geared toward pediatric patients with bleeding and clotting disorders. Dr. Zia also leads the multidisciplinary “Young Women’s Blood Disorders Clinic” at Children's Medical Center, focused on improving the care of adolescent girls with menorrhagia and bleeding disorders as well as girls with thrombophilia first and only program in North Texas that specializes in the diagnosis and treatment of bleeding and clotting disorders and accompanying reproductive problems in young women. Dr. Zia has a particular interest in the use of global coagulation assays, like thromboelatography and thrombin generation, in the diagnosis and management of congenital bleeding and clotting disorders. Current projects are focused on 1) elucidating the biology of hormonal induced thrombosis and predictors of thrombosis in young girls on oral contraceptives, 2) outcomes of thrombosis in the pediatric population including recurrent thrombosis and post-thrombotic syndrome, 3) Improving diagnostic strategies and quality of life in adolescent females with menorrhagia and bleeding disorders and 4) thromboprophylaxis in pediatric patients undergoing orthopedic surgeries. Dr. Zia is also the institutional co-investigator for several clinical trials investigating new treatments in hemostasis and thrombosis, including new medications for hemophilia, von Willebrand disease, and blood clots.


Medical School
King Edward Medical University, Pakistan (2002)
University of Oklahoma Health Science Center (2007), Pediatrics
Children's Hospital of Michigan (2009), Pediatrics
Children's Hospital of Michigan (2012), Pediatric Hematology/oncology
Childrens Hospital of Michigan (2013), Pediatric Hemostasis/thrombosis


Featured Publications LegendFeatured Publications

Abnormal Uterine Bleeding in Young Women with Blood Disorders.
Dickerson KE, Menon NM, Zia A Pediatr. Clin. North Am. 2018 Jun 65 3 543-560
Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis.
Menon N, Sarode R, Zia A Blood Adv 2018 Jan 2 2 142-145
High Hemoglobin Is an Independent Risk Factor for the Development of Hemolysis During Pediatric Extracorporeal Life Support.
Jenks CL, Zia A, Venkataraman R, Raman L J Intensive Care Med 2017 Jan 885066617708992
Use of a Modified Classic BT Shunt in a Patient With Multiple Conduit Obstructions With Positive Lupus Anticoagulant.
Bhattarai P, Zia A, Forbess JM, Guleserian KJ, Hupp SR, Pirolli T World J Pediatr Congenit Heart Surg 2017 Jan 2150135116688180
Glutathione Depletion, Pentose Phosphate Pathway Activation, and Hemolysis in Erythrocytes Protecting Cancer Cells from Vitamin C Induced Oxidative Stress.
Zhang ZZ, Lee EE, Sudderth J, Yue Y, Zia A, Glass D, DeBerardinis RJ, Wang RC J. Biol. Chem. 2016 Sep


Featured Books Legend Featured Books

Honors & Awards

  • CCRAC Research Award in Junior Investigator Category
  • George R. Buchanan Teaching award for excellence in Fellow Education
  • American Society of Hematology “Clinical Research Training Institute” Award
  • Wolf Zuelzer Research Award
    Award Recipient for outstanding research during pediatric Hematology/Oncology fellowship (2012)
  • Chief Fellow in Pediatric Hematology Oncology
  • National Hemophilia Foundation (NHF) Clinical Fellowship Award
    Award Recipient with $200,000 funded during award period (2011-2013)

Professional Associations/Affiliations

  • International Society on Thrombosis and Haemostasis (2014)
  • Hemostasis and Thrombosis Research Society (2011)
  • National Hemophilia Foundation (NHF) (2011)
  • American Society of Hematology (ASH) (2009)
  • American Society of Pediatric Hematology/Oncology (ASPHO) (2009)
  • Pakistan Medical and Dental Council (2002)